A2 share price frenzy – but is the US formula market worth it?

A2 share price frenzy – but is the US formula market worth it?
The American dream may not be worth it for A2. (Image: Getty)
Jenny Ruth
Some investors believe accessing the US infant formula market would be a big deal for Fonterra and the A2 Milk Company, and trading in A2’s shares last week highlighted that fact.An Australian Financial Review (AFR) journalist got a little over her skis on Tuesday and published a story saying A2 could get US Food & Drug Administration (FDA) approval “as soon as this week”.Both Fonterra and A2 have been waiting for this approval since they applied in late May after the FDA made public it was looking to facilitate infant for...

More Primary Sector

Fonterra’s NZ milk collections hit five-year high
Primary Sector

Fonterra’s NZ milk collections hit five-year high

The increased production comes as forecast milk prices point to record levels.

Riley Kennedy 02 Jul 2025
MPI led the Fieldays charge
Primary Sector

Cameron Bagrie: MPI led the Fieldays charge

Fieldays was a class act, once again, with MPI as the lead actor.

Cameron Bagrie 26 Jun 2025